Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica

Fumitaka Shimizu, Kristin L. Schaller, Gregory P. Owens, Anne C. Cotleur, Debra Kellner, Yukio Takeshita, Birgit Obermeier, Thomas J. Kryzer, Yasuteru Sano, Takashi Kanda, Vanda A. Lennon, Richard M. Ransohoff, Jeffrey L. Bennett

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

Neuromyelitis optica (NMO) is an inflammatory disorder mediated by antibodies to aquaporin-4 (AQP4) with prominent blood-brain barrier (BBB) breakdown in the acute phase of the disease. Anti-AQP4 antibodies are produced mainly in the periphery, yet they target the astrocyte perivascular end feet behind the BBB. We reasoned that an endothelial cell-targeted autoantibody might promote BBB transit of AQP4 antibodies and facilitate NMO attacks. Using monoclonal recombinant antibodies (rAbs) frompatients with NMO, we identified two that strongly bound to the brain microvascular endothelial cells (BMECs). Exposure of BMECs to these rAbs resulted in nuclear translocation of nuclear factor κB p65, decreased claudin-5 protein expression, and enhanced transit of macromolecules. Unbiased membrane proteomics identified glucose-regulated protein 78 (GRP78) as the rAb target. Using immobilized GRP78 to deplete GRP78 antibodies from pooled total immunoglobulin G (IgG) of 50 NMO patients (NMO-IgG) reduced the biological effect ofNMO-IgG onBMECs. GRP78 was expressed on the surface ofmurineBMECs in vivo, and repeated administration of a GRP78-specific rAb caused extravasation of serum albumin, IgG, and fibrinogen into mouse brains. Our results identify GRP78 antibodies as a potential component ofNMO pathogenesis and GRP78 as a candidate target for promoting central nervous system transit of therapeutic antibodies.

Original languageEnglish (US)
Article numberaai9111
JournalScience translational medicine
Volume9
Issue number397
DOIs
StatePublished - Jul 5 2017

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica'. Together they form a unique fingerprint.

  • Cite this

    Shimizu, F., Schaller, K. L., Owens, G. P., Cotleur, A. C., Kellner, D., Takeshita, Y., Obermeier, B., Kryzer, T. J., Sano, Y., Kanda, T., Lennon, V. A., Ransohoff, R. M., & Bennett, J. L. (2017). Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica. Science translational medicine, 9(397), [aai9111]. https://doi.org/10.1126/scitranslmed.aai9111